Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-18, Stock:NVS, The news for the past five days is as follows:
2019-07-11: NEWS1: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS2: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS3: Amgen and Novartis drop Alzheimer's-prevention study after patients worsened.NEWS4: Signature Select Canadian Fund's Top 6 Buys.NEWS5: Amneal (AMRX) Down on Guidance Update & Restructuring Plan.NEWS6: Amgen, Novartis abandon two Alzheimer’s drug studies.NEWS7: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.NEWS8: Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill.
2019-07-12: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: Here's Why NeoGenomics Stock Rose 74% in the First Half of the Year.NEWS4: Here's Why NeoGenomics Stock Rose 74% in the First Half of the Year.NEWS5: What Happened in the Stock Market Today.NEWS6: Aimmune Down on Negative ICER Review on Allergy Candidate.NEWS7: Aimmune Down on Negative ICER Review on Allergy Candidate.NEWS8: Amgen & Novartis' Alzheimer Studies End in Another Failure.NEWS9: Amgen & Novartis' Alzheimer Studies End in Another Failure.NEWS10: Amgen & Novartis' Alzheimer Studies End in Another Failure.NEWS11: Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug.NEWS12: Aimmune Down on Negative ICER Review on Allergy Candidate.NEWS13: Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails.NEWS14: The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study.
2019-07-15: NEWS1: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS2: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.NEWS3: J&J Falls Amid Reports of Criminal Probe Into Talcum Powder.
2019-07-16: NEWS1: Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings?.NEWS2: Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings?.NEWS3: Should You Pick Up Novartis (NVS) Before Q2 Earnings?.NEWS4: Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings?.NEWS5: Eisai boosts focus on Alzheimer's with new research facility, funding.NEWS6: Novartis' (NVS) Crizanlizumab Gets Priority Review From FDA.NEWS7: Novartis' (NVS) Crizanlizumab Gets Priority Review From FDA.NEWS8: Eton's Ophthalmic Solution Candidate Gets CRL, Shares Fall.NEWS9: Eton's Ophthalmic Solution Candidate Gets CRL, Shares Fall.NEWS10: Novartis' (NVS) Crizanlizumab Gets Priority Review From FDA.NEWS11: Eton's Ophthalmic Solution Candidate Gets CRL, Shares Fall.
2019-07-17: NEWS1: The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On.NEWS2: The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On.NEWS3: Pre-Market Earnings Report for July 18, 2019 :  UNH, HON, PM, UNP, DHR, MS, TSM, BBT, BX, NVS, STI, PPG.NEWS4: Pre-Market Earnings Report for July 18, 2019 :  UNH, HON, PM, UNP, DHR, MS, TSM, BBT, BX, NVS, STI, PPG.NEWS5: The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On.NEWS6: Why Earnings Season Could Be Great for Novartis (NVS).NEWS7: Mallinckrodt (MNK) Discontinues Sclerosis Study on Acthar Gel.NEWS8: Mallinckrodt (MNK) Discontinues Sclerosis Study on Acthar Gel.NEWS9: Merck's Antibiotic Recarbrio Gets FDA Nod for Infections.NEWS10: Merck's Antibiotic Recarbrio Gets FDA Nod for Infections.NEWS11: Why Earnings Season Could Be Great for Novartis (NVS).NEWS12: Merck's Antibiotic Recarbrio Gets FDA Nod for Infections.NEWS13: Mallinckrodt (MNK) Discontinues Sclerosis Study on Acthar Gel.NEWS14: Trade Talk Cools Off Record-Setting Market.NEWS15: Should You Pick Up Novartis (NVS) Before Q2 Earnings?.NEWS16: Should You Pick Up Novartis (NVS) Before Q2 Earnings?.

Answer: Rise